Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

roche.com

Investor Update

Get the latest updates from Investor Update directly as they happen.

Follow now 352 followers

Latest posts

Last updated 6 days ago

Invitation to Roche’s Half Year Results 2025 Presentation

6 days ago

  Roche will publish its Half Year Results of 2025 prior to the...

Early data suggest Roche’s NXT007 may have the potential to provide haemostatic normalisation in people with haemophilia A

9 days ago

Positive phase I/II data presented at the 2025 International Society on Thrombosis...

Roche’s Lunsumio and Polivy combination significantly prolongs remission for people with relapsed or refractory large B-cell lymphoma

11 days ago

Pivotal phase III SUNMO study demonstrated an 11.5 month median progression-free survival...

Reminder: Invitation to Roche’s Virtual Hematology Investor Event

15 days ago

  We are pleased to invite investors and analysts to participate in our...

Roche to advance prasinezumab into Phase III development for early-stage Parkinson's disease

16 days ago

Results from Phase IIb PADOVA and longer term follow-up data suggest clinical...

New data show Roche’s Itovebi significantly extended survival in a certain type of HR-positive advanced breast cancer

about 1 month ago

The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than...

Invitation to Roche’s Virtual Hematology Investor Event

about 1 month ago

We are pleased to invite investors and analysts to participate in our...

CHMP recommends EU approval of Roche’s Itovebi for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer

about 1 month ago

Positive recommendation based on phase III INAVO120 data showing ItovebiTM (inavolisib) in...

Roche announces new collaboration with Broad Clinical Labs to accelerate adoption of cutting-edge SBX sequencing technology

about 1 month ago

The strategic collaboration with Broad Clinical Labs will explore and develop applications...